SelectImmune Pharma appoints acting CEO
Professor Godaly is familiar with all aspects of the company and has been actively involved in its development for several years. She was appointed Chief Medical Officer of SelectImmune Pharma in 2020 and has served on the Board of Directors since 2019.
Gabriela Godaly is a clinical trials expert and her contributions are extremely valuable for the rapidly evolving clinical trials program of SelectImmune Pharma.
For more information, please contact:
Chairman of the board SelectImmune Pharma AB
Phone: +46 709 42 65 49
E-mail: [email protected]